252 related articles for article (PubMed ID: 19691205)
21. Treating osteoporosis.
Smith G; Stassen L; Flint S
Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199
[No Abstract] [Full Text] [Related]
22. Beyond bisphosphonates: thrombophilia, hypofibrinolysis, and jaw osteonecrosis.
McMahon RE; Bouquot JE; Glueck CJ; Griep J
J Oral Maxillofac Surg; 2006 Nov; 64(11):1704-5. PubMed ID: 17052602
[No Abstract] [Full Text] [Related]
23. Bisphosphonates--what the dentist needs to know: practical considerations.
Fantasia JE
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):53-60. PubMed ID: 19371815
[No Abstract] [Full Text] [Related]
24. Specialists play down risk of jaw condition.
Stassen LF
J Ir Dent Assoc; 2008; 54(4):153. PubMed ID: 18780680
[No Abstract] [Full Text] [Related]
25. Do Fosamax-type drugs increase the risk of osteonecrosis of the jaw for patients receiving dental implants?
Wynn RL
Gen Dent; 2008; 56(5):410-1. PubMed ID: 18683394
[No Abstract] [Full Text] [Related]
26. Bisphosphonates and oral health.
Ritter AV; Padilla R
J Esthet Restor Dent; 2008; 20(1):74-5. PubMed ID: 18237344
[No Abstract] [Full Text] [Related]
27. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
[No Abstract] [Full Text] [Related]
28. Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients.
Wass JA
Clin Radiol; 2008 Jan; 63(1):78-9. PubMed ID: 18068793
[No Abstract] [Full Text] [Related]
29. Standard protocols.
Kini G
Br Dent J; 2007 Oct; 203(8):440. PubMed ID: 17965662
[No Abstract] [Full Text] [Related]
30. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
Radfar L; Masood F
J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
[TBL] [Abstract][Full Text] [Related]
31. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.
Sarasquete ME; González M; San Miguel JF; García-Sanz R
Oral Dis; 2009 Sep; 15(6):382-7. PubMed ID: 19413677
[TBL] [Abstract][Full Text] [Related]
32. Bisphosphonate induced osteonecrosis of the jaws: unravelling uncertainty in disease causality.
Kelleher FC; McKenna M; Collins C; Brady G; Collins I; Crown J
Acta Oncol; 2007; 46(5):702-4. PubMed ID: 17562449
[No Abstract] [Full Text] [Related]
33. Bisphosphonate-induced osteonecrosis of the jaws: a challenge, a responsibility, and an opportunity.
Marx RE
Int J Periodontics Restorative Dent; 2008 Feb; 28(1):5-6. PubMed ID: 18351197
[No Abstract] [Full Text] [Related]
34. Slumbering time-bomb.
Dean F
Br Dent J; 2006 Sep; 201(5):249. PubMed ID: 16960582
[No Abstract] [Full Text] [Related]
35. A cautious approach.
Girgis S
Br Dent J; 2010 May; 208(10):439-40. PubMed ID: 20489743
[No Abstract] [Full Text] [Related]
36. Bisphosphonate medications--the good, the bad, and the ugly.
Bourgeois SL
Tex Dent J; 2009 Jul; 126(7):596-604. PubMed ID: 19753815
[No Abstract] [Full Text] [Related]
37. American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition.
Colella G; Campisi G; Fusco V
J Oral Maxillofac Surg; 2009 Dec; 67(12):2698-9. PubMed ID: 19925998
[No Abstract] [Full Text] [Related]
38. Comprehensive review of bisphosphonate therapy: implications for the oral and maxillofacial surgery patient.
Ruggiero SL; Carlson ER; Assael LA
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):1. PubMed ID: 19371808
[No Abstract] [Full Text] [Related]
39. Bisphosphonates and bone...what have we learned?
Guttenberg SA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):769-72. PubMed ID: 18835534
[No Abstract] [Full Text] [Related]
40. Bisphosphonate-associated osteonecrosis of the jaw.
Khan A
Can Fam Physician; 2008 Jul; 54(7):1019-21. PubMed ID: 18625828
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
